NICE guidance on newer drugs for epilepsy in adults

British Medical Journal

Volumn 328, Issue 7451, 2004, Pages 1273-1274

  Perucca, Emilio ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; BARBITURIC ACID DERIVATIVE; CARBAMAZEPINE; CONTRACEPTIVE AGENT; ETIRACETAM; FELBAMATE; GABAPENTIN; LAMOTRIGINE; ORAL CONTRACEPTIVE AGENT; OXCARBAZEPINE; PHENYTOIN; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

ADULT; BONE MARROW TOXICITY; COST EFFECTIVENESS ANALYSIS; DATA ANALYSIS; DRUG COST; DRUG EFFICACY; EDITORIAL; EPILEPSY; FETOTOXICITY; FETUS MALFORMATION; HUMAN; LIVER TOXICITY; PATIENT CARE; PRACTICE GUIDELINE; PRENATAL EXPOSURE; PRIORITY JOURNAL; QUALITY OF LIFE; SIDE EFFECT; UNITED KINGDOM;

EID: 2542612883     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.328.7451.1273     Document Type: Editorial

References (13)

1. Perucca E. Clinical pharmacology and therapeutic use of the new anti-epileptic drugs. Fund Clin Pharmacol 2001;15:405-17.
2. National Institute for Clinical Excellence. Newer drugs for epilepsy. London: NICE London, 2004. www.nice.org.uk/TA076guidance (accessed 4 May 2004). (Technology Appraisal 76.)
3. Marson AG, Kadir ZA, Hutton JL, Chadwick DJ. The new antiepileptic drugs: a systematic review of their efficacy and tolerability. Epilepsia 1997;38:859-80.
4. Perucca E, Tomson T. Monotherapy trials with the new antiepileptic drugs: Study designs, practical relevance and ethical implications. Epilepsy Res 1999;33:247-62.
5. Patsalos PN, Perucca E. Clinically important drug interactions in epilepsy: Interactions between antiepileptic drugs and other drugs. Lancet Neurol 2003;2:473-81.
6. Practice parameter: management issues for women with epilepsy (summary statement). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 1998;51:944-8.
7. Diagnosis and management of epilepsy in adults. A national clinical guideline. Edinburgh: Scottish Intercollegiate Guidelines Network, 2003.
8. Samren EB, van Duijn CM, Christiaens GC, Hofman A, Lindhout D. Antiepileptic drug regimens and major congenital abnormalities in the offspring. Ann Neurol 1999;46:739-46.
9. Kaneko S, Battino D, Andermann E, Wada K, Kan R, Takeda A, et al. Congenital malformations due to antiepileptic drugs. Epilepsy Res 1999;33:145-58.
10. Kaaja E, Kaaja R, Hülesmaa V. Major malformations in offspring of women with epilepsy. Neurology 2003;60:575-9.
11. Wide K, Winbladh B, Källén B. Major malformations in infants exposed to antiepileptic drugs in utero, with emphasis on carbamazepine and valproic acid. A nation-wide population-based register study. Acta Paediatr 2004;93:174-6.
12. Morrow J. Which antiepileptic drug is safest in pregnancy? [Abstract]. Epilepsia 2003;44(suppl 8):60.
13. Johnson JE, Pryor FM, Ramsay ER, Rowan AJ, Collins JF, DVA CSP 428 Study Group. Recruiting older patients into randomized controlled trials: an update. [Abstract]. Epilepsia 2002;43(suppl 7):165.